OpenEvidence
頭部巨獸為醫生及其他醫療專業人員提供基於醫學文獻的 AI 臨床決策支援,並輔助生成診療記錄與編碼建議。
- 每月造訪次數
- 15.2M
- 上升5.8%較上月2026 年 10 月
- 公開營收
- 未公開
- 暫無公開營收證據
- 入門價
- 免費
- 沒有月付訂閱價
- 首次發布
- 2 年前
- 2024-08-15 · 估算
訪問
行銷動作
發布、搜尋與內容、引薦、促銷OpenEvidence collaborates with ACP to integrate clinical guidance產品動態
ACP's clinical guidance and Annals of Internal Medicine are being integrated into OpenEvidence to provide cited answers for physicians.
11 月 9 日 · 14 天前X 原帖
當時 每月造訪次數 15.2M在 Google Play 發布發布
OpenEvidence provides accurate answers at the point of care (NPI REQUIRED)
2024 年 9 月 30 日 · 2 年前發布頁
在 App Store 發布發布
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of c
2024 年 8 月 15 日 · 2 年前發布頁
商店資料
- 評分
- ★ 4.9211.4K 個評分
- 價格與內購
- 免費
- 當前版本
- v2.9.2091 MB
- 首次上架
- 2024-08-15
* NEJM, JAMA, and NCCN content partnership * Streamlined experience during answer writing * Performance enhancements
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide. Now sourcing from over 300+ medical journals, as well as the FDA and CDC. OpenEvidence is an official AI partner of The New England Journal of Medicine and the Journal of American Medical Association (and their 11 specialty journals), and has content agreements, partnerships and collaborations with: NCCN ACC ADA ACEP AAFP AAOS AAOHNS and more. OpenEvidence is only available for health care professionals. Users must verify their health care professional status before using OpenEvidence. TESTIMONIALS “I've been using OpenEvidence for the last week - it has been amazing! Able to narrow down on results quickly and find information that I wasn't able to do with Google/PubMed searches on my own.” - Dr. John Lee, MD. Physician & Faculty Member, Harvard Medical School “OpenEvidence can be the foundational technology to power all clinical decision tools.” - Dr. Antonio Jorge Forte, MD. Director of MayoExpert, Mayo Clinic “OpenEvidence is more up-to-date than UpToDate. And more useful regardless, since it’s interactive, and you can ask it questions, and get very specific answers about specific medical fact patterns in a patient case. It’s like having a curbside consult with a team of expert physicians, but that you can carry around with you in your pocket.” - Dr. Ram Dandillaya, MD. Clinical Chief, Department of Cardiology, Cedars-Sinai Medical Center “I am in community practice and medical director of a community cancer center. OpenEvidence has been an incredible lifeline for daily practitioners.” - C.J., Oncologist “OpenEvidence is absolutely fantastic. I use it a gazillion times a day.” - J.A., Neurologist “OpenEvidence’s efforts to make medicine more evidence-based are invaluable. The shift from judgment to calculation can reduce the level of noise currently found in medicine.” - Daniel Kahneman, Nobel Prize Laureate (In Memoriam) “It is light years ahead of the next best medical oriented AI I have used.” - R.E.., Oncologist
OpenEvidence provides accurate answers at the point of care (NPI REQUIRED)
- 評分
- ★ 4.864,377 個評分
- 安裝規模
- 100,000+至少 100K 次安裝
- 價格與內購
- 免費無內購
- 當前版本
- v2.9.19
* NEJM, JAMA, and NCCN content partnership * Streamlined experience during answer writing * Performance enhancements
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide. Now sourcing from over 300+ medical journals, as well as the FDA and CDC. OpenEvidence is an official AI partner of The New England Journal of Medicine and the Journal of American Medical Association (and their 11 specialty journals), and has content agreements, partnerships and collaborations with: • NCCN • ACC • ADA • ACEP • AAFP • AAOS • AAOHNS and more. OpenEvidence is only available for health care professionals. Users must verify their health care professional status before using OpenEvidence. TESTIMONIALS “I've been using OpenEvidence for the last week - it has been amazing! Able to narrow down on results quickly and find information that I wasn't able to do with Google/PubMed searches on my own.” - Dr. John Lee, MD. Physician & Faculty Member, Harvard Medical School “OpenEvidence can be the foundational technology to power all clinical decision tools.” - Dr. Antonio Jorge Forte, MD. Director of MayoExpert, Mayo Clinic “OpenEvidence is more up-to-date than UpToDate. And more useful regardless, since it’s interactive, and you can ask it questions, and get very specific answers about specific medical fact patterns in a patient case. It’s like having a curbside consult with a team of expert physicians, but that you can carry around with you in your pocket.” - Dr. Ram Dandillaya, MD. Clinical Chief, Department of Cardiology, Cedars-Sinai Medical Center “I am in community practice and medical director of a community cancer center. OpenEvidence has been an incredible lifeline for daily practitioners.” - C.J., Oncologist “OpenEvidence is absolutely fantastic. I use it a gazillion times a day.” - J.A., Neurologist “OpenEvidence’s efforts to make medicine more evidence-based are invaluable. The shift from judgment to calculation can reduce the level of noise currently found in medicine.” - Daniel Kahneman, Nobel Prize Laureate (In Memoriam) “It is light years ahead of the next best medical oriented AI I have used.” - R.E.., Oncologist
商店圖示、評分分布、安裝量級與宣傳截圖來自 Apple App Store、Google Play 與 Chrome 應用商店公開頁面。
流量來源
訪問構成
這個網站的訪問管道與國家構成還沒有資料。
搜尋
站點權重 —網域名稱註冊 2004-01-02
這個網站還沒有搜尋關鍵字資料。
流量資料:Vaneform
定價
尚未識別出定價頁,或該頁面沒有公開價格。
官網快照
關鍵頁面
電腦版與行動端存檔官網快照待採集。
設計
白色畫布搭配暖灰側欄,襯線品牌字與細描邊控件形成層級,橙色按鈕和淡粉公告條點亮整體。
首屏畫面預覽 · 點擊放大
首屏畫面講了什麼與轉化路徑
“America’s Official Medical Knowledge Platform”
左側固定導航,主區居中排列品牌字、輸入框與快捷提問,底部橫置註冊欄。
首屏畫面轉化路徑:居中標題加輸入框 + 首屏畫面可互動演示或工具 → 首屏畫面直接輸入或試用
色板 · 點擊複製
- 字體與排版
- 7.0
- 色彩與對比
- 7.0
- 構圖與留白
- 7.0
- 細節與工藝
- 6.0
- 風格辨識度
- 5.0
結構
- 字體
- Lora / Schibsted Grotesk
- 首屏畫面版式
- 居中標題加輸入框
- 主視覺
- 首屏畫面可互動演示或工具
- 轉化動作
- 首屏畫面直接輸入或試用
- 信任背書
- 無顯式背書
- 導航
- 左側應用側邊欄
- 明暗與密度
- 淺色 · 留白多
- 圓角與層級
- 中圓角 · 有陰影
預覽 AI 設計說明全文(含 :root CSS 變量與版式規則)只寫風格參數,禁止復刻該產品的品牌名、標誌、文案與圖片
問題與證據
- OpenEvidence 的網站造訪次數是多少?
- Vaneform 估算 2026-10 網站造訪次數為 15.2M。造訪次數包含重複訪問,付費客戶數與收入需分別查看對應證據。來源
- OpenEvidence 是什麼產品,支援哪些平台?
- OpenEvidence 歸屬「醫療與護理機構」市場領域:為醫生及其他醫療專業人員提供基於醫學文獻的 AI 臨床決策支援,並輔助生成診療記錄與編碼建議。 支援平台包括:行動應用。
同分類研究對象
這些產品屬於同一目錄分類。選型時請進一步核對客戶任務、功能與部署要求。
正在研究「OpenEvidence」?
免費登入自動獲贈 7 天 Pro 體驗:持續追蹤流量與改價動態、評估差異化切入,或免費認領自有產品。